Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

Romy D. Zwittink; Cornelia C.H. Wielders; The Dutch CPE and MRSA Surveillance Study Groups; Daan W. Notermans; Nelianne J. Verkaik; Annelot F. Schoffelen; Sandra Witteveen; Varisha A. Ganesh; Angela De Haan; Jeroen Bos; Jacinta Bakker; Caroline Schneeberger Van Der Linden; Ed J. Kuijper; Sabine C. De Greeff; Antoni P.A. Hendrickx

doi:10.2807/1560-7917.ES.2022.27.50.2200896

Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

Romy D. Zwittink, Cornelia C.H. Wielders, The Dutch CPE and MRSA Surveillance Study Groups, Daan W. Notermans, Nelianne J. Verkaik, Annelot F. Schoffelen, Sandra Witteveen, Varisha A. Ganesh, Angela De Haan, Jeroen Bos, Jacinta Bakker, Caroline Schneeberger Van Der Linden, Ed J. Kuijper, Sabine C. De Greeff, Antoni P.A. Hendrickx^*

^*Corresponding author for this work

Medical Microbiology & Infectious Diseases

Research output: Contribution to journal › Article › Academic › peer-review

31 Citations (Scopus)

89 Downloads (Pure)

Abstract

Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority of the MDRO represent globally spread epidemic lineages and that 60% contain New Delhi metallo-β-lactamase (NDM) genes. Professionals should be aware of an increase in such MDRO associated with migration and medical evacuation of people from Ukraine.

Original language	English
Article number	2200896
Journal	Eurosurveillance
Volume	27
Issue number	50
DOIs	https://doi.org/10.2807/1560-7917.ES.2022.27.50.2200896
Publication status	Published - 15 Dec 2022

Bibliographical note

Funding Information:
This study was carried out as part of the Dutch National CPE and MRSA surveillance, as part of the regular activities of the RIVM, financed by the Dutch Ministry of Health, Welfare and Sport.

Publisher Copyright:
© 2022 European Centre for Disease Prevention and Control (ECDC). All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2807/1560-7917.ES.2022.27.50.2200896Licence: CC BY

Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022Final published version, 239 KBLicence: CC BY

Cite this

Zwittink, R. D., Wielders, C. C. H., The Dutch CPE and MRSA Surveillance Study Groups, Notermans, D. W., Verkaik, N. J., Schoffelen, A. F., Witteveen, S., Ganesh, V. A., De Haan, A., Bos, J., Bakker, J., Van Der Linden, C. S., Kuijper, E. J., De Greeff, S. C., & Hendrickx, A. P. A. (2022). Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022. Eurosurveillance, 27(50), Article 2200896. https://doi.org/10.2807/1560-7917.ES.2022.27.50.2200896

@article{a90bc7e3ba624bd19592f9e623f11fe4,

title = "Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022",

abstract = "Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority of the MDRO represent globally spread epidemic lineages and that 60% contain New Delhi metallo-β-lactamase (NDM) genes. Professionals should be aware of an increase in such MDRO associated with migration and medical evacuation of people from Ukraine.",

author = "Zwittink, {Romy D.} and Wielders, {Cornelia C.H.} and {The Dutch CPE and MRSA Surveillance Study Groups} and Notermans, {Daan W.} and Verkaik, {Nelianne J.} and Schoffelen, {Annelot F.} and Sandra Witteveen and Ganesh, {Varisha A.} and {De Haan}, Angela and Jeroen Bos and Jacinta Bakker and {Van Der Linden}, {Caroline Schneeberger} and Kuijper, {Ed J.} and {De Greeff}, {Sabine C.} and Hendrickx, {Antoni P.A.}",

note = "Funding Information: This study was carried out as part of the Dutch National CPE and MRSA surveillance, as part of the regular activities of the RIVM, financed by the Dutch Ministry of Health, Welfare and Sport. Publisher Copyright: {\textcopyright} 2022 European Centre for Disease Prevention and Control (ECDC). All rights reserved.",

year = "2022",

month = dec,

day = "15",

doi = "10.2807/1560-7917.ES.2022.27.50.2200896",

language = "English",

volume = "27",

journal = "Eurosurveillance",

issn = "1025-496X",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "50",

}

Zwittink, RD, Wielders, CCH, The Dutch CPE and MRSA Surveillance Study Groups, Notermans, DW, Verkaik, NJ, Schoffelen, AF, Witteveen, S, Ganesh, VA, De Haan, A, Bos, J, Bakker, J, Van Der Linden, CS, Kuijper, EJ, De Greeff, SC & Hendrickx, APA 2022, 'Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022', Eurosurveillance, vol. 27, no. 50, 2200896. https://doi.org/10.2807/1560-7917.ES.2022.27.50.2200896

TY - JOUR

T1 - Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

AU - Zwittink, Romy D.

AU - Wielders, Cornelia C.H.

AU - The Dutch CPE and MRSA Surveillance Study Groups

AU - Notermans, Daan W.

AU - Verkaik, Nelianne J.

AU - Schoffelen, Annelot F.

AU - Witteveen, Sandra

AU - Ganesh, Varisha A.

AU - De Haan, Angela

AU - Bos, Jeroen

AU - Bakker, Jacinta

AU - Van Der Linden, Caroline Schneeberger

AU - Kuijper, Ed J.

AU - De Greeff, Sabine C.

AU - Hendrickx, Antoni P.A.

N1 - Funding Information: This study was carried out as part of the Dutch National CPE and MRSA surveillance, as part of the regular activities of the RIVM, financed by the Dutch Ministry of Health, Welfare and Sport. Publisher Copyright: © 2022 European Centre for Disease Prevention and Control (ECDC). All rights reserved.

PY - 2022/12/15

Y1 - 2022/12/15

N2 - Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority of the MDRO represent globally spread epidemic lineages and that 60% contain New Delhi metallo-β-lactamase (NDM) genes. Professionals should be aware of an increase in such MDRO associated with migration and medical evacuation of people from Ukraine.

AB - Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority of the MDRO represent globally spread epidemic lineages and that 60% contain New Delhi metallo-β-lactamase (NDM) genes. Professionals should be aware of an increase in such MDRO associated with migration and medical evacuation of people from Ukraine.

UR - http://www.scopus.com/inward/record.url?scp=85144355737&partnerID=8YFLogxK

U2 - 10.2807/1560-7917.ES.2022.27.50.2200896

DO - 10.2807/1560-7917.ES.2022.27.50.2200896

M3 - Article

C2 - 36695467

AN - SCOPUS:85144355737

SN - 1025-496X

VL - 27

JO - Eurosurveillance

JF - Eurosurveillance

IS - 50

M1 - 2200896

ER -

Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this